YCBD Company Profile and Key Details

Q: Who are the executives of YCBD?

Mr. Lance BlundellGen. CounselDr. Sibyl Swift Ph.D.CSO, Vice President of Regulatory Affairs & DirectorMr. Matthew CoapmanChief Marketing OfficerMr. John WestonDirector of Investor RelationsRobert PettwayDirector of PRMr. Raymond Scott CoffmanCo-Founder & Vice ChairmanMr. Kevin MacDermottPrincipal Executive Officer & PresMr. Francisco MangualSenior Vice President of SalesMs. Shannon CharlesChief Marketing OfficerZeb BookerChief Technology OfficerMr. T. Ronan KennedyInterim Chief Executive Officer, Principal Executive Officer, Chief Financial Officer, Sec. & TreasurerDr. Sybil Swift Ph.D.CSO, Vice President of Regulatory Affairs & Director

AMEX : YCBD

cbdMD

$0.64

-0.0177-2.69%

At Close 4:00 PM

69.18

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

cbdMD, Inc. (YCBD) stock declined over -2.69%, trading at $0.64 on AMEX, down from the previous close of $0.66. The stock opened at $0.63, fluctuating between $0.63 and $0.70 in the recent session.

Stock Snapshot

0.6577

Prev. Close

6.72M

Market Cap

0.6254

Day Low

-1.58

P/E Ratio

-0.40625

EPS (TTM)

-0.9

Cash Flow per Share

0.63

Open

10.5M

Number of Shares

0.7

Day High

98.26%

Free Float in %

2.38

Book Value

276.15K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 15, 2026	0.63	0.70	0.63	0.64	276.15K
Jul 14, 2026	0.69	0.70	0.66	0.66	196.4K
Jul 13, 2026	0.79	0.82	0.62	0.68	919.47K
Jul 10, 2026	0.81	0.82	0.78	0.79	207.96K
Jul 09, 2026	0.76	0.82	0.76	0.81	248.22K
Jul 08, 2026	0.73	0.78	0.69	0.75	261.86K
Jul 07, 2026	0.70	0.74	0.69	0.74	253.99K
Jul 06, 2026	0.69	0.71	0.68	0.71	87.12K
Jul 02, 2026	0.68	0.69	0.67	0.69	72.4K
Jul 01, 2026	0.68	0.70	0.66	0.68	106.65K
Jun 30, 2026	0.68	0.70	0.66	0.67	122.92K
Jun 29, 2026	0.70	0.71	0.66	0.70	264.39K
Jun 26, 2026	0.70	0.74	0.69	0.70	227.11K
Jun 25, 2026	0.68	0.73	0.65	0.70	448.38K
Jun 24, 2026	0.70	0.70	0.65	0.66	132.76K
Jun 23, 2026	0.71	0.71	0.66	0.67	72.22K
Jun 22, 2026	0.70	0.72	0.69	0.69	55.63K
Jun 18, 2026	0.67	0.72	0.67	0.72	146.67K
Jun 17, 2026	0.69	0.69	0.66	0.69	63K
Jun 16, 2026	0.68	0.69	0.66	0.67	107.72K

Contact Details

Charlotte, NC 28217

United States

https://www.cbdmd.com 704 445 3060

About Company

cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.

Stock Peers

YCBD-PA

0.21141+18.51%

cbdMD, Inc.$1.35 CPHI

0.4852+78.92%

China Pharma Holdings, Inc.$1.10 APUS

-0.0245-3.35%

Apimeds Pharmaceuticals US, Inc$0.71 MNK

-0.0599-14.97%

Mallinckrodt plc$0.34 ZOM

-0.0002-0.21%

Zomedica Corp.$0.10

Company Overview

cbdMD, Inc. (AMEX:YCBD) closed at $0.64 USD, losing -$0.02 (-2.69%) from the previous close of $0.66. The stock is currently mid-range between its 52-week high and low $0.47 and $2.56. With a market capitalization of about $6.72 million, cbdMD, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.13). Key stats such as the average daily volume over the past year has been around 1.37 million shares, volume is running light vs its 52-week average. Headquartered in Charlotte, NC, cbdMD, Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO T. Ronan Kennedy, the company employs approximately 42 people and listed since November 17, 2017. cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products.

Technical Performance

YCBD has shown weak momentum, losing -28.36% over the past week and -27.74% over the past quarter, though year-to-date performance is down -38.44%. Short-term trend indicators are mixed aligned (SMA20 13.62%, SMA50 -7.78%, SMA200 8.09%). The stock’s 14-day RSI is 55.39 (neutral), while the ATR of 0.13 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -72.84% below its high and over 110.47% above its low. Average 10-day trading volume of 306.40 thousand shares is below the 3-month average of 1.26 million, indicating normal recent market interest.

Valuation Metrics

cbdMD, Inc. trades at a P/E ratio of -1.59, slightly below the S&P 500 average, with a price-to-sales ratio of 0.34 and a price-to-book ratio of 0.73 suggesting the stock is closer to book value. The P/FCF stands at -0.04, also above market averages.

Dividend & Fair Value

cbdMD, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.05. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $2.00 to $2.00. The high target offers 212.5% upside. The low target suggests 212.5% downside. The mean target is $2.00. This offers 212.5% upside. cbdMD, Inc. earnings surprise history is a mixed track record. The quarter that ended May 14, 2026, missed forecasts by 60.0%. The prior quarter beat by -33.33%. Over the last six quarters, Apple has recorded several small beats. These include 375.68% in February 13, 2025.

Shareholding & Insider Activity

cbdMD, Inc. has 8.91 million shares outstanding. The public float is 8.76 million shares, elevated short interest at 0.97% of float. This equals 86.02 thousand shares. The short ratio is 0.67 days. Institutional investors hold 10.03% of the float. Insiders own 10.68%. Sumichrast Martin A. holds 1.43 million shares, Ghiloni Peter J. has 300.00 thousand shares and Elliott Mark S has 51.68 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, cbdMD has not generated any revenue. Returns are negative, with ROA at 0.00% and ROE at -60.55%.
On valuation metrics, cbdMD trades at a P/E of -1.59, P/S of 0.34 and P/B of 0.73. The current ratio is 2.82 and quick ratio is 1.71. Operationally, the company’s inventory turnover is 2.52 and cash conversion cycle is 112.80 days. Debt-to-equity is 0.04, supported by a cash flow-to-debt ratio of -5.97.

Quarterly Financial Highlights

For the quarter ended Sep 30, 2025, cbdMD posted revenue of $0.00, down slightly from $19.48M in the prior quarter. Net income was- $4.38B (EPS - $1.09).
The company ended the quarter with $0.00 in cash and short-term investments, a total debt of $778.24M, and net debt of $778.24M. Total assets were $0.00, with equity of $7.23B. Financials further reflected weakness, with operating cash flow of $0.00, free cash flow of - $184.17M, and capital expenditures of - $184.17M.

Price Forecast & Outlook

Our AI price prediction model suggests that cbdMD, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 14.06%, with price expected at $0.73 by July 28, 2026, within a range of $0.70 to $0.76 3-Month Outlook: Projected fall of -50.0%, reaching $0.32 by October 12, 2026, with a range of $0.22 to $0.41. 1-Year Outlook: Projected gain of 54.69%, with price at $0.99 by July 14, 2027, within a range of $0.00 to $0.00.

Key Takeaways

cbdMD, Inc. (AMEX:YCBD) shares are down -38.44% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows cbdMD, Inc. trading at a premium to the broader market with a P/E of -1.59. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $2.50, suggesting 290.62% upside. Our AI forecast model points to short-term strength (14.06% over two weeks), a medium-term fall (-50.0% over three months), and a longer-term gain (54.69% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current cbdMD, Inc. (YCBD) stock price?

cbdMD, Inc. (AMEX: YCBD) stock price is $0.64 in the last trading session. During the trading session, YCBD stock reached the peak price of $0.70 while $0.63 was the lowest point it dropped to. The percentage change in YCBD stock occurred in the recent session was -2.69% while the dollar amount for the price change in YCBD stock was - $0.02.

YCBD's industry and sector of operation?

The AMEX listed YCBD is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. cbdMD, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of YCBD?

Mr. Lance Blundell
Gen. Counsel
Dr. Sibyl Swift Ph.D.
CSO, Vice President of Regulatory Affairs & Director
Mr. Matthew Coapman
Chief Marketing Officer
Mr. John Weston
Director of Investor Relations
Robert Pettway
Director of PR
Mr. Raymond Scott Coffman
Co-Founder & Vice Chairman
Mr. Kevin MacDermott
Principal Executive Officer & Pres
Mr. Francisco Mangual
Senior Vice President of Sales
Ms. Shannon Charles
Chief Marketing Officer
Zeb Booker
Chief Technology Officer
Mr. T. Ronan Kennedy
Interim Chief Executive Officer, Principal Executive Officer, Chief Financial Officer, Sec. & Treasurer
Dr. Sybil Swift Ph.D.
CSO, Vice President of Regulatory Affairs & Director

How YCBD did perform over past 52-week?

YCBD's closing price is 36.17% higher than its 52-week low of $0.47 where as its distance from 52-week high of $2.56 is -75%.

How many employees does YCBD have?

Number of YCBD employees currently stands at 42.

Link for YCBD official website?

Official Website of YCBD is: https://www.cbdmd.com

How do I contact YCBD?

YCBD could be contacted at phone 704 445 3060 and can also be accessed through its website. YCBD operates from 8845 Red Oak Boulevard, Charlotte, NC 28217, United States.

How many shares of YCBD are traded daily?

YCBD stock volume for the day was 276.15K shares. The average number of YCBD shares traded daily for last 3 months was 1.37M.

What is the market cap of YCBD currently?

The market value of YCBD currently stands at $6.72M with its latest stock price at $0.64 and 10.5M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	42
Beta	2.13
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	September
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

YCBD Company Profile and Key Details

cbdMD

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook